An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia.

[1]  Emilio Ros,et al.  Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. , 2008, The American journal of cardiology.

[2]  Jonathan C. Cohen,et al.  Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes , 2008, Human molecular genetics.

[3]  S. Humphries,et al.  A functional mutation in the LDLR promoter (−139C>G) in a patient with familial hypercholesterolemia , 2007, European Journal of Human Genetics.

[4]  E. Ros,et al.  Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia , 2007, Journal of Inherited Metabolic Disease.

[5]  E. Ros,et al.  Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes. , 2007, The Journal of clinical endocrinology and metabolism.

[6]  M. Willingham,et al.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. , 2007, The Journal of clinical investigation.

[7]  P. Jones,et al.  Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? , 2007, Life sciences.

[8]  M. Willingham,et al.  Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface Facilitates Free Cholesterol Uptake* , 2006, Journal of Biological Chemistry.

[9]  Jonathan C. Cohen,et al.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Schadt,et al.  Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment. , 2005, Genomics.

[11]  J. Kastelein,et al.  Update of the molecular basis of familial hypercholesterolemia in The Netherlands , 2005, Human mutation.

[12]  F. Civeira,et al.  Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. , 2005, Metabolism: clinical and experimental.

[13]  F. Lammert,et al.  New insights into the genetic regulation of intestinal cholesterol absorption. , 2005, Gastroenterology.

[14]  M. Pocovi,et al.  Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. , 2005, Clinical chemistry.

[15]  Y. Ioannou,et al.  Inactivation of NPC1L1 Causes Multiple Lipid Transport Defects and Protects against Diet-induced Hypercholesterolemia* , 2005, Journal of Biological Chemistry.

[16]  Andrew D. Johnson,et al.  Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. , 2005, Pharmacology & therapeutics.

[17]  M. Stephens,et al.  Accounting for Decay of Linkage Disequilibrium in Haplotype Inference and Missing-data Imputation , 2022 .

[18]  Jianjun Liu,et al.  Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis* , 2004, Journal of Biological Chemistry.

[19]  Luquan Wang,et al.  Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .

[20]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[21]  Bruce Blumberg,et al.  Active repression by unliganded retinoid receptors in development , 2003, The Journal of cell biology.

[22]  R. Rowntree,et al.  DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding , 2002, Human Genetics.

[23]  B. Levy,et al.  Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. , 2000, Genomics.

[24]  M. Rubio,et al.  Perfil lipídico de la población española, estudio DRECE (Dieta y Riesgo de Enfermedad Cardiovascular en España) , 1999 .

[25]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[26]  Y. Kesäniemi,et al.  Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population , 1987, European journal of clinical investigation.

[27]  R. Galetto,et al.  A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. , 2002, Journal of lipid research.

[28]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[29]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.